Woodline Partners »

Enliven Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $21M 806k 25.54
2024-06-30 $17M 723k 23.37
2024-03-31 $7.0M 396k 17.59
2023-09-30 $5.4M 396k 13.66